Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension
Clinical trial NCT03499873 · COMPLETED
Trial details
- NCT number
- NCT03499873
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-28
- Primary completion
- 2018-10-31
- Enrollment
- 448
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.